Autopsy report · NCT06832423

CAN CREATINE SUPPLEMENTATION IMPROVE PERFORMANCE in ROCK CLIMBERS?

“Unable to obtain dietary intervention due to manufacturer withdrawing product from market.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Bangor University

Sponsor type

University, hospital or other

Conditions

Rock Climbing

Interventions

Creatine monohydrate; Placebo

Participants

0

Sites

1

Countries

United Kingdom

Trials that died the same way

• MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
  “Product withdrawn from clinical development” (61% match in meaning)
• Fungal Fiber for Gut Health
  “The sponsor company was dissolved, resulting in insufficient funding to continue production of the investigational dietary supplement.” (60% match in meaning)
• 2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML
  “Pharmaceutical Company withdrew support and investigational product” (59% match in meaning)
• Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood
  “We were unable to procure the supplement for this study.” (59% match in meaning)
• Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
  “The study stopped due to marketing approval by the FDA.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.